Hugel smooths out wrin­kles with FDA, wins ap­proval for Botox com­peti­tor

There’s a new Botox com­peti­tor in town: Hugel Aes­thet­ics won ap­proval for Lety­bo, its neu­ro­tox­in in­jec­tion for mod­er­ate to se­vere frown lines.

De­spite its avail­abil­i­ty …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.